Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation
Clinical trial NCT03983967 · COMPLETED
Trial details
- NCT number
- NCT03983967
- Sponsor
- GC Cell Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2021-09-09
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.